Skip to main content

Advertisement

Fig. 5 | Clinical Epigenetics

Fig. 5

From: Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging

Fig. 5

DNA methylation of RARB, RASSF1, and GSTP1 as biomarker of risk increase. a Methylation levels according to risk increase in voided urine samples; b methylation levels according to risk increase in catheterized urine samples; c comparison of ROC curves of the gene methylation levels in voided urine samples alone and combined with PSA; d comparison of ROC curves of the gene methylation levels in catheterized urine samples alone and combined with PSA. RASSF1 and GSTP1 together are referred to as the two genes. Significant P values are in bold

Back to article page